In Vitro and In Vivo Antitumor Assay of Mitochondrially Targeted Fluorescent Half-Sandwich Iridium(III) Pyridine Complexes-Reference-Cited by-同舟云学术

In Vitro and In Vivo Antitumor Assay of Mitochondrially Targeted Fluorescent Half-Sandwich Iridium(III) Pyridine Complexes

Published:2023-02-10 Issue:8 Volume:62 Page:3395-3408
ISSN:0020-1669
Container-title:Inorganic Chemistry
language:en
Short-container-title:Inorg. Chem.

Author:

Wang Liyan¹,Liu Xicheng¹^ORCID,Wu Yuting²,He Xian¹,Guo Xiaohui¹,Gao Wenshan¹,Tan Lin¹,Yuan Xiang-Ai¹^ORCID,Liu Jinfeng²,Liu Zhe¹^ORCID

Affiliation:

1. Institute of Anticancer Agents Development and Theranostic Application, School of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China

2. College of Life Sciences, Qufu Normal University, Qufu 273165, Shandong, China

Funder

Taishan Scholar Project of Shandong Province

Natural Science Foundation of Shandong Province

Publisher

American Chemical Society (ACS)

Subject

Inorganic Chemistry,Physical and Theoretical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.inorgchem.2c03333

Reference69 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Role of Curcumin in reducing toxicity and adverse effects in locally advanced and metastatic breast cancer patients

3. The side effects of platinum-based chemotherapy drugs: a review for chemists

4. Advances in the design of organometallic anticancer complexes

5. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ferrocene-modified half-sandwich iridium(III) and ruthenium(II) propionylhydrazone complexes and anticancer application;Journal of Inorganic Biochemistry;2024-08

2. Studies of Anticancer Activities In Vitro and In Vivo for Butyltin(IV)–Iridium(III) Imidazole–Phenanthroline Complexes with Aggregation-Induced Emission Properties;Inorganic Chemistry;2024-07-25

3. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy;Bioorganic Chemistry;2024-06

4. Chlorido-pentamethylcyclopentadienyl-[2-(2-pyridyl-кN)-ferrocenyl-кC]-iridium(III);Molbank;2024-02-02

5. Configurationally regulated half-sandwich iridium(III)-ferrocene heteronuclear metal complexes: Potential anticancer agents;Journal of Inorganic Biochemistry;2023-12